Verastem (VSTM) Tax Provisions (2024 - 2025)
Verastem's (VSTM) quarterly Tax Provisions came in at -$44.0 million in Q4 2025, down 22094.5% year-on-year from N/an in Q4 2024, and down 22094.5% quarter-over-quarter from $200000.0 in Q4 2024.
Verastem (VSTM) Tax Provisions (2024 - 2025) Analysis & Trends
Verastem's Tax Provisions history runs 2 years deep, the most recent figure standing at -$44.0 million for Q4 2025.
- On a quarterly basis, Tax Provisions fell 22094.5% year-over-year to -$44.0 million in Q4 2025; TTM through Mar 2026 was -$44.0 million, a 22094.5% decrease from a year earlier, with the FY2025 full-year figure at -$44.0 million, down 22094.5% from the prior year.
- Tax Provisions declined to -$44.0 million in Q4 2025 per VSTM's latest filing, from $200000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $200000.0 in Q4 2024 and bottomed at -$44.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -43.99 Mn |
| Dec 31, 2024 | 200,000.00 |